John C. Jacobs

John C. Jacobs

President and CEOatNovavax· In proxies 2023–2025

Pay in FY2025+74% from the year before · Novavax stock -16.4% the same year

John C. Jacobs was paid $8.9M in FY2025 (Dec), up 74%. Novavax stock fell 16.4% that year.

Pay$100 in the stock at the end of FY22 → $65
Pay is from the Summary Compensation Table of each Novavax proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovavaxPublic company · 3 yr
    • President and CEO2023 – Present · 3 yrStock in role +16%

Roles come from the proxy statements of each company.

Boards1

  • NovavaxDirector · 1 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?